US2001041737A1PendingUtilityA1
Enhancing the toxicity of warfarin in rodents
Assignee: RECKITT BENCKISER INC DELAWAREPriority: Mar 9, 1998Filed: Jun 18, 2001Published: Nov 15, 2001
Est. expiryMar 9, 2018(expired)· nominal 20-yr term from priority
Inventors:Richard Poché
A01N 25/004A01N 43/16
46
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The presence of a small amount of an antibiotic, such as metronidazole or a salt or derivative thereof, in warfarin-containing rodent baits enhances the toxicity of warfarin against rodents which have heretofore shown apparent resistance to warfarin.
Claims
exact text as granted — not AI-modifiedI claim:
1 . A method of enhancing the efficiency of warfarin in a rodenticide which comprises adding to a warfarin-containing rodenticidal composition an antibiotic selected from the group consisting of cotrimoxazole, metronidazole, erythromycin, fluconazole, isoniazid, miconazole, ciprofloxacin, and itraconazole, or a salt of said antibiotic, the amount of antibiotic being sufficient to inhibit the action of bacteria present in the gastrointestinal tract of a rodent.
2 . A method according to claim 1 in which the antibiotic is metronidazole.
3 . A method for killing rodents which comprises causing the rodents to ingest a composition comprising a rodenticidally effective amount of warfarin and an antibiotic selected from the group consisting of cotrimoxazole, metronidazole, erythromycin, fluconazole, isoniazid, miconazole, ciprofloxacin, and itraconazole, or a salt of said antibiotic, in an amount sufficient to inhibit the action of bacteria present and to reduce the amount of vitamin K in the gastrointestinal tract of said rodents.
4 . A method according to claim 3 in which the antibiotic is metronidazole or a salt thereof.
5 . A composition for killing rodents comprising (a) a rodenticidally effective amount of warfarin and (b) an antibiotic selected from the group consisting of cotrimoxazole, metronidazole, erythromycin, fluconazole, isoniazid, miconazole, ciprofloxacin, and itraconazole, or a salt of said antibiotic, in an amount sufficient to inhibit the action of bacteria present in the gastrointestinal tract of the rodent.
6 . A composition according to claim 5 in which said composition comprises the antibiotic or a salt of the antibiotic suspended in a solid carrier.
7 . A composition according to claim 6 in which the antibiotic or salt thereof is present in an amount of from about 0.05 to 1.0 percent based on the weight of the composition.
8 . A composition according to claim 7 in which warfarin is present in an amount of from about 50 to about 300 ppm.
9 . A composition according to claim 5 in which the antibiotic is metronidazole or a salt thereof.Join the waitlist — get patent alerts
Track US2001041737A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.